GENI 📈 Generic Sweden publ AB - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0001790791
GENI: Messaging Services, Digital Communication Platforms, IT Consulting
Generic Sweden AB, a technology company, provides messaging services for all applications. It also offers a platform for digital communication services. The company was incorporated in 1993 and is headquareted in Stockholm, Sweden. Web URL: https://www.generic.se
Additional Sources for GENI Stock
GENI Stock Overview
| Market Cap in USD | 56m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
GENI Stock Ratings
| Growth 5y | 40.6% |
| Fundamental | 64.0% |
| Dividend | 72.1% |
| Rel. Strength Industry | -115 |
| Analysts | - |
| Fair Price Momentum | 47.46 SEK |
| Fair Price DCF | 39.38 SEK |
GENI Dividends
| Dividend Yield 12m | 3.06% |
| Yield on Cost 5y | 7.77% |
| Annual Growth 5y | 33.03% |
| Payout Consistency | 97.8% |
GENI Growth Ratios
| Growth Correlation 3m | 63.4% |
| Growth Correlation 12m | -28.7% |
| Growth Correlation 5y | 34% |
| CAGR 5y | 21.06% |
| CAGR/Mean DD 5y | 0.47 |
| Sharpe Ratio 12m | 0.14 |
| Alpha | -28.64 |
| Beta | 1.21 |
| Volatility | 29.03% |
| Current Volume | 10.1k |
| Average Volume 20d | 13.1k |
What is the price of GENI stocks?
As of December 22, 2024, the stock is trading at SEK 50.40 with a total of 10,098 shares traded.
Over the past week, the price has changed by -3.16%, over one month by +6.52%, over three months by +8.89% and over the past year by -3.26%.
As of December 22, 2024, the stock is trading at SEK 50.40 with a total of 10,098 shares traded.
Over the past week, the price has changed by -3.16%, over one month by +6.52%, over three months by +8.89% and over the past year by -3.26%.
Is Generic Sweden publ AB a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Generic Sweden publ AB (ST:GENI) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 64.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GENI as of December 2024 is 47.46. This means that GENI is currently overvalued and has a potential downside of -5.83%.
Yes, based on ValueRay Fundamental Analyses, Generic Sweden publ AB (ST:GENI) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 64.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GENI as of December 2024 is 47.46. This means that GENI is currently overvalued and has a potential downside of -5.83%.
Is GENI a buy, sell or hold?
Generic Sweden publ AB has no consensus analysts rating.
Generic Sweden publ AB has no consensus analysts rating.
What are the forecast for GENI stock price target?
According to ValueRays Forecast Model, GENI Generic Sweden publ AB will be worth about 53.1 in December 2025. The stock is currently trading at 50.40. This means that the stock has a potential upside of +5.38%.
According to ValueRays Forecast Model, GENI Generic Sweden publ AB will be worth about 53.1 in December 2025. The stock is currently trading at 50.40. This means that the stock has a potential upside of +5.38%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 5.6 | -89% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 53.1 | 5.4% |